Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:32
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 29 条
[1]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[2]   Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry [J].
Barba, Raquel ;
Bisbe, Josep ;
Alcala Pedrajas, Jose Nicolas ;
Toril, Jesus ;
Monte, Rafael ;
Sanchez Munoz-Torrero, Juan Francisco ;
Monreal, Manuel .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (04) :457-463
[3]  
Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
[4]  
Brass LM, 1996, STROKE, V27, P1173
[5]   Recurrent stroke risk is higher than cardiac event risk after initial stroke/transient ischemic attack [J].
Brown, DL ;
Lisabeth, LD ;
Roychoudhury, C ;
Ye, YN ;
Morgenstern, LB .
STROKE, 2005, 36 (06) :1285-1287
[6]   Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry [J].
Camafort, M. ;
Alvarez-Rodriguez, L. R. ;
Munoz-Torrero, J. F. S. ;
Sahuquillo, J. C. ;
Lopez-Jimenez, L. ;
Coll, R. ;
Monreal, M. .
DIABETIC MEDICINE, 2011, 28 (01) :73-80
[7]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[8]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[9]   Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting A North-American perspective [J].
Faxon, David P. ;
Eikelboom, John W. ;
Berger, Peter B. ;
Holmes, David R. ;
Bhatt, Deepak L. ;
Moliterno, David J. ;
Becker, Richard C. ;
Angiolillo, Dominick J. .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (04) :572-584
[10]   Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials [J].
Flaker, Greg C. ;
Gruber, Michael ;
Connolly, Stuart J. ;
Goldman, Steven ;
Chaparro, Sandra ;
Vahanian, Alec ;
Halinen, Matti O. ;
Horrow, Jay ;
Halperin, Jonathan L. .
AMERICAN HEART JOURNAL, 2006, 152 (05) :967-973